Antibe Therapeutics Valuation
| ATBPF Stock | USD 0.22 0.00 0.00% |
Antibe Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Antibe Therapeutics from analyzing the firm fundamentals such as Current Valuation of (19.98 M), return on equity of -0.4, and Shares Owned By Insiders of 7.79 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Antibe Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Antibe Therapeutics is based on 3 months time horizon. Increasing Antibe Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Antibe pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Antibe Therapeutics. Since Antibe Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Antibe Pink Sheet. However, Antibe Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.22 | Real 0.18 | Hype 0.22 | Naive 0.22 |
The real value of Antibe Pink Sheet, also known as its intrinsic value, is the underlying worth of Antibe Therapeutics Company, which is reflected in its stock price. It is based on Antibe Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Antibe Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Antibe Therapeutics helps investors to forecast how Antibe pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Antibe Therapeutics more accurately as focusing exclusively on Antibe Therapeutics' fundamentals will not take into account other important factors: Antibe Therapeutics Total Value Analysis
Antibe Therapeutics is presently projected to have takeover price of (19.98 M) with market capitalization of 22.59 M, debt of 205 K, and cash on hands of 50.19 M. The negative valuation of Antibe Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Antibe Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(19.98 M) | 22.59 M | 205 K | 50.19 M |
Antibe Therapeutics Asset Utilization
One of the ways to look at asset utilization of Antibe is to check how much profit was generated for every dollar of assets it reports. Antibe Therapeutics shows a negative utilization of assets of -0.16 percent, losing $0.001642 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Antibe Therapeutics shows how discouraging it operates for each dollar spent on its assets.Antibe Therapeutics Ownership Allocation
Antibe Therapeutics holds a total of 52.14 Million outstanding shares. Antibe Therapeutics shows 7.79 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Antibe Therapeutics Profitability Analysis
Net Loss for the year was (25.06 M) with profit before overhead, payroll, taxes, and interest of 3.55 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Antibe Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Antibe Therapeutics and how it compares across the competition.
About Antibe Therapeutics Valuation
The pink sheet valuation mechanism determines Antibe Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Antibe Therapeutics. We calculate exposure to Antibe Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Antibe Therapeutics's related companies.Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.
8 Steps to conduct Antibe Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Antibe Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Antibe Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Antibe Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Antibe Therapeutics' revenue streams: Identify Antibe Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Antibe Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Antibe Therapeutics' growth potential: Evaluate Antibe Therapeutics' management, business model, and growth potential.
- Determine Antibe Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Antibe Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Antibe Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Antibe Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 52.1 M | |
| Forward Price Earnings | 73.5294 | |
| Retained Earnings | -111 M |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |